  When investigating suitability for surgery, people with drug-refractory focal
epilepsy may have intracranial EEG (iEEG) electrodes implanted to localise
seizure onset. Diffusion-weighted magnetic resonance imaging (dMRI) may be
acquired to identify key white matter tracts for surgical avoidance. Here, we
investigate whether structural connectivity abnormalities, inferred from dMRI,
may be used in conjunction with functional iEEG abnormalities to aid
localisation and resection of the epileptogenic zone (EZ), and improve surgical
outcomes in epilepsy.
  We retrospectively investigated data from 43 patients with epilepsy who had
surgery following iEEG. Twenty five patients (58%) were free from disabling
seizures (ILAE 1 or 2) at one year. For all patients, T1-weighted and
diffusion-weighted MRIs were acquired prior to iEEG implantation. Interictal
iEEG functional, and dMRI structural connectivity abnormalities were quantified
by comparison to a normative map and healthy controls respectively.
  First, we explored whether the resection of maximal (dMRI and iEEG)
abnormalities related to improved surgical outcomes. Second, we investigated
whether the modalities provided complementary information for improved
prediction of surgical outcome. Third, we suggest how dMRI abnormalities may be
useful to inform the placement of iEEG electrodes as part of the pre-surgical
evaluation using a patient case study.
  Seizure freedom was 15 times more likely in those patients with resection of
maximal dMRI and iEEG abnormalities (p=0.008). Both modalities were separately
able to distinguish patient outcome groups and when combined, a decision tree
correctly separated 36 out of 43 (84%) patients based on surgical outcome.
  Structural dMRI could be used in pre-surgical evaluations, particularly when
localisation of the EZ is uncertain, to inform personalised iEEG implantation
and resection.
